Fortrea beats Q2 revenue estimates, raises 2025 guidance

Fortrea Holdings

06/08/2025 11:50

Overview

Fortrea Q2 2025 revenue of $710.3 mln beats analyst expectations

Adjusted EBITDA of $54.9 mln exceeds estimates, per LSEG data

Company raises 2025 revenue guidance to $2.6 bln-$2.7 bln

Outlook

Fortrea raises 2025 revenue guidance to $2,600 mln-$2,700 mln

Company affirms 2025 adjusted EBITDA guidance of $170 mln-$200 mln

Fortrea assumes stable foreign exchange rates for 2025 forecast

Result Drivers

GOODWILL IMPAIRMENT - Net loss impacted by $309.1 mln non-cash goodwill impairment charge

COST SAVINGS - Cost saving initiatives remain on track, contributing to operational commitments

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$710.30 mln
$629.40 mln (9 Analysts)
Q2 EPS
-$4.14
Q2 Net Income
-$374.90 mln
Q2 Adjusted EBITDA
Beat
$54.90 mln
$39.20 mln (9 Analysts)
Q2 Operating Income
-$330.30 mln


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 8 "hold" and 2 "sell" or "strong sell"

The average consensus recommendation for the biotechnology & medical research peer group is "buy."

Wall Street's median 12-month price target for Fortrea Holdings Inc is $5.50, about 19.3% below its August 5 closing price of $6.56

The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release: ID:nGNX76SHnT

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)